Navigation Links
IRIDEX Reports 2012 First Quarter Results
Date:5/3/2012

erience with a variety of medical devices including systems and consumables. This is a first step in improving manufacturing efficiencies previously highlighted by the Company.
  • The Company launched a new non-invasive, in-office glaucoma procedure based on its proprietary MicroPulse™ technology.  The new glaucoma therapy, a tissue-sparing, repeatable therapy called MicroPulse Laser Trabeculoplasty (MLT), was introduced by IRIDEX at the recent American Society of Cataract and Refractive Surgery (ASCRS).
  • Conference Call IRIDEX management will conduct a conference call later today, Thursday, May 3, 2012 at 5:00 p.m. Eastern Time.  Interested parties may access the live conference call via telephone by dialing (877) 941-2332 (U.S.) or (480) 629-9773 (International) and quoting Conference ID 4533749, or by visiting the Company's website at www.iridex.com. A telephone replay will be available beginning on Thursday, May 3, 2012 through Thursday, May 10, 2012 by dialing (800) 406-7325 (U.S.) or (303) 590-3030 (International) and entering Access Code 4533749. In addition, later today an archived version of the webcast will be available on the Company's website at www.iridex.com.

    About IRIDEX IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independe
    '/>"/>

    SOURCE IRIDEX Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. IRIDEX Introduces New ENT Laser Delivery Devices at AAO-HNSF Annual Meeting
    2. IRIDEX Introduces Modular Multi-Wavelength Laser Solution at the American Academy of Ophthalmology
    3. IRIDEX Introduces IQ 532 Dual Port Green Laser System at the American Academy of Ophthalmology
    4. Ruediger Naumann-Etienne Appointed to IRIDEX Board of Directors
    5. IRIDEX Announces Fourth Quarter and Full Year 2009 Conference Call and Release Date
    6. IRIDEX Reports Fourth Quarter and Full Year 2009 Financial Results
    7. IRIDEX Announces First Quarter 2010 Conference Call and Release Date
    8. IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems
    9. IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery
    10. IRIDEX Announces Second Quarter 2010 Conference Call and Release Date
    11. IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/29/2015)... , June 29, 2015  PDL BioPharma, Inc. ... entered into a credit agreement with CareView Communications, Inc. ... to $40 million of secured debt financing. CareView is ... on patient care monitoring. Under the credit ... million of debt financing in two tranches of $20 ...
    (Date:6/29/2015)... Minn. , June 29, 2015 EnteroMedics ... of devices that use neuroblocking technology to treat obesity, ... it has commenced an underwritten public offering of units. ... stock, Series A warrants to purchase common stock and ... purchase of units in the offering would result in ...
    (Date:6/29/2015)... , June 29, 2015  Allergan plc ... intends to release second quarter 2015 financial results ... open of the U.S. financial markets. The Company will ... a.m. Eastern Daylight Time on Thursday, August 6, ... to access the call is U.S./ Canada ...
    Breaking Medicine Technology:PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 2PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 4EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 2Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 3
    ... Radiologic (vRad), a technology-enabled national radiology practice, has again ... market segment by independent research and consulting firm KLAS. ... interviews conducted by KLAS and is published in the ... Software & Professional Services report. In ...
    ... Reportlinker.com announces that a new market research report ... Novo Nordisk A/S: PharmaVitae Profile ... This analysis examines the historical ... prescription pharmaceutical sector. The profile encompasses global company ...
    Cached Medicine Technology:Virtual Radiologic Ranked #1 for Teleradiology Services for Third Consecutive Year 2Reportlinker Adds Novo Nordisk A/S: PharmaVitae Profile 2
    (Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... of aspiring data scientists and analysts who are currently attending an accredited American ... growth of data has provided new insight into healthcare, the environment, political campaigns, ...
    (Date:6/30/2015)... ... June 30, 2015 , ... Curly Hair Solutions™ is honoured to attend ... in the US, featuring products from all over the world. For the first time ... a line of hair styling products focused entirely on meeting the needs of all ...
    (Date:6/29/2015)... ... , ... Aespala Medspa and Plastic Surgery is proud to introduce the newest ... Dr. Dreyfuss received his medical degree from Emory University in Atlanta before completing a ... Fellowship at the University of Chicago. He has taught and practiced medicine in the ...
    (Date:6/29/2015)... ... June 30, 2015 , ... Career Step, ... website intended for executives and administrators with hospitals, healthcare providers, and insurance companies. ... product is a result of comprehensive research and implementation of web design and ...
    (Date:6/29/2015)... ... June 29, 2015 , ... ... group series as part of its support program. This discussion series is part ... and other support services to those affected by mesothelioma. , The six week ...
    Breaking Medicine News(10 mins):Health News:Izenda Offers Embedded BI and Analytics Scholarship 2Health News:Izenda Offers Embedded BI and Analytics Scholarship 3Health News:Curly Hair Solutions™ Showcases Entire Curl Keeper™ Collection at Cosmoprof Las Vegas July 12 - 14 2Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 2Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 3Health News:Career Step Launches New Website to Better Meet Needs of Partners, Clients and Others Searching for Corporate Training Solutions 2Health News:Mesothelioma Organization Provides Support for Patients and Families 2Health News:Mesothelioma Organization Provides Support for Patients and Families 3
    ... fats should be listed on food labels to help cut ... // ,These experts putting forward their arguments in this ... in order to combat the UK's number one killer, estimated ... in Europe. ,In addition cardiovascular disease is reported ...
    ... activities under a common umbrella, Orchid Chemicals & Pharmaceuticals Ltd ... acquiring a 26 per cent stake // , for over ... a majority 74 per cent stake in Bexel Pharma and ... part of an agreement reached between the two companies to ...
    ... Indoor Air Act, celebrating its third anniversary, has reduced ... //according to a study conducted by RTI International. ... State Department of Health’s Tobacco Control Program, exposure to ... New York in the year following the implementation of ...
    ... in fertility treatment if they donate eggs for controversial cloning ... a scheme for ‘egg sharing' so as to advance work ... agree for this scheme and pass on their spare eggs ... IVF treatment by almost half. , ,The researcher ...
    ... a drugs trial which went wrong could now develop serious ... ,The six volunteers of the trials at Northwick Park ... year. ,Martyn Day, a solicitor for several of ... most terrible future". ,Parexel, a clinical research organization, ...
    ... An Oregon Health & Science University study has demonstrated ... can assist in keeping// a tab on the pattern ... the initial signs of onset of dementia. The study ... the 10th International Conference on Alzheimer's Disease and Related ...
    Cached Medicine News:Health News:Scientists Push for Labeling of all Fats to Avoid Heart Disease 2Health News:New York’s Secondhand Smoke Exposure Continues to Declin 2Health News:IVF Price To Be Reduced If Women Opt For Egg Sharing Scheme 2Health News:IVF Price To Be Reduced If Women Opt For Egg Sharing Scheme 3Health News:Sensors placed at home capable of signaling onset of early signs of dementia in elderly 2Health News:Sensors placed at home capable of signaling onset of early signs of dementia in elderly 3
    ... third-generation allergy test , 3gAllergy is a ... provides quantitative determination of allergen-specific IgE at ... and lot-to-lot reproducibility. The assay delivers reliable ... you identify, monitor and manage patients with ...
    ... System is part of a series of modular ... ranging from 3.5 to 8.0 mm. Matching a ... system provides convenience and flexibility for the orthopaedic ... system may be customized using two of three ...
    The DePuy ACE 8.0mm Cannulated Cancellous Screw incorporates TiMAX to provide superior strength, fatigue resistance and a lower modulus of elasticity when compared to similar stainless steel devices....
    ... The VersaNail System is a complete system ... to use with TTC fusion surgery. The ... specialists and integrates clinical research and engineering ... Because every patient is different, and because ...
    Medicine Products: